Development of a new subclavian arterial infusion chemotherapy method for locally or recurrent advanced breast cancer using an implanted catheter-port system after redistribution of arterial tumor supply.
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE.
Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2.
A review of treatment options employed in relapsed/refractory AML.
Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, Dharmaratna D, Dandwani M, Moin K.
Hematology. 2023 Dec;28(1):2196482. doi: 10.1080/16078454.2023.2196482.
Updates on targeted therapies for acute myeloid leukaemia.
Kayser S, Levis MJ.
Br J Haematol. 2022 Jan;196(2):316-328. doi: 10.1111/bjh.17746. Epub 2021 Aug 4.
Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease.
Burton C, Allen P, Herrera AF.
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433502. doi: 10.1200/EDBK_433502.
The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
Tambaro R, Scambia G, Di Maio M, Pisano C, Barletta E, Iaffaioli VR, Pignata S.
Crit Rev Oncol Hematol. 2004 Oct;52(1):33-44. doi: 10.1016/j.critrevonc.2004.05.003.
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.
Coccolini F, Fugazzola P, Ansaloni L, Sartelli M, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Catena F.
Acta Biomed. 2018 Dec 17;89(8-S):104-109. doi: 10.23750/abm.v89i8-S.7904.
Cholangiocarcinoma Therapeutics: An Update.
Nguyen MLT, Toan NL, Bozko M, Bui KC, Bozko P.
Curr Cancer Drug Targets. 2021;21(6):457-475. doi: 10.2174/1568009621666210204152028.
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
Boussios S, Seraj E, Zarkavelis G, Petrakis D, Kollas A, Kafantari A, Assi A, Tatsi K, Pavlidis N, Pentheroudakis G.
Crit Rev Oncol Hematol. 2016 Dec;108:164-174. doi: 10.1016/j.critrevonc.2016.11.006. Epub 2016 Nov 15.
A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes.
O'Halloran N, Lowery A, Curran C, McLaughlin R, Malone C, Sweeney K, Keane M, Kerin M.
Clin Breast Cancer. 2019 Oct;19(5):377-382. doi: 10.1016/j.clbc.2019.04.011. Epub 2019 May 2.
Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer.
Thoen H, Ceelen W, Boterberg T, Van Daele E, Pattyn P.
Radiother Oncol. 2015 Apr;115(1):16-21. doi: 10.1016/j.radonc.2015.03.012. Epub 2015 Mar 25.
